CHAI sessions at AIDS 2022

This is the current list of sessions that CHAI is participating in at AIDS 2022. Please also note that this page is continuously being updated as participants and sessions are confirmed. Presentation links will be updated when recordings are available, so check back regularly.

Satellite sessions organized by CHAI

• The Road to Zero: successes, learnings, and the work ahead to end advanced HIV disease-related mortality
  • Friday, July 29 at 1 pm EDT / 7 pm CEST
  • CHAI Presenters: James Conroy and Ikechukwu Amamilo
• Differentiated Testing Services: Optimizing program design to enhance testing and linkage
  • Friday, July 29 at 1 pm EDT/ 7 pm CEST
  • CHAI Presenter: Katherine Guerra
• HIV and Viral Hepatitis: integrating programs and financing to accelerate the achievement of twin goals to eliminate HIV and viral hepatitis by 2030
  • Friday, July 29 at 6:15 pm EDT/ 12:15 am CEST
  • CHAI Speakers: David Ripin and Alida Ngwije
• The next frontier for HIV treatment optimization: Lessons from the past and visions for the future
  • Saturday, July 30 at 5:45 pm EDT / 11:45 pm CEST
  • CHAI Presenter: Carolyn Amole
• Empowering communities in global and national policy and implementation: lessons from the Unitaid Optimal Project
  • Sunday, July 31 at 5:45 pm EDT / 11:45 pm CEST
  • CHAI Presenters: Carolyn Amole and Williams Eigege

Satellite sessions where CHAI is participating

• How catalytic partnerships address market inefficiencies and lead to sustainable and affordable access to healthcare
  • Friday, July 29 at 07:45 am EDT / 1:45 pm CEST
  • CHAI Speaker: Alan Staple
• Accessing long-acting HIV prevention and treatment innovations: Landscape, service delivery, and pathways to affordability
  • Friday, July 29 at 4:30 pm EDT / 10:30 pm CEST
  • CHAI Speaker: David Ripin
• Opportunities for expanding access to HIV self-testing
  • Saturday, July 30 at 8:00 am EDT / 2:00 pm CEST
  • CHAI Speaker: David Ripin
• Demand, delivery and data for decision-making: How market preparation for the Dual Prevention Pill is reimagining prevention programs for a future with MPTs
  • Sunday, July 31 at 5:45 pm EDT / 11:45 pm CEST
• Advanced HIV care & monitoring optimization: Fast and accurate results
  • Monday, August 1 at 5:45 pm EDT / 11:45 pm CEST
  • CHAI Speaker: Chishamiso Mudenyanga

Symposium

• Co-infections: What is new?
  • Sunday, July 31 at 10:30 am EDT/4:30 pm CEST
  • CHAI Speaker: Nagalingeswaran Kumarasamy

Oral abstract sessions

• How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment?
  • Thursday, July 28 at 1:00 pm EDT / 7 pm CEST
  • CHAI Presenter: Sydney Rosen
• Outcomes in paediatric and adolescent HIV: Beyond ART
  • Friday, July 29 at 10:30 am EDT/ 4:30 pm CEST
  • CHAI presenter: Jason Brophy
• The catalytic role of dual HIV/syphilis rapid diagnostic tests in accelerating national elimination of mother-to-child-transmission in Nigeria
  • Sunday, July 31 at 10:30 am EDT/ 4:30 pm CEST
  • CHAI presenter: Andrew Storey

e-Poster presentations

• HIV risk screening: a systematic and efficient approach for improving identification of HIV-positive children in Ethiopia
  D. Haile, G. Aschale, M. Mergia, M. Bereda, T. Abamo, A. Silesh *, Z. Hika, M. Getachew, J. Joseph, N. Medina-Jaudes, S. Dowling, J. Drakes, K. Suggu
• Does differentiated service delivery for HIV treatment change healthcare providers’ workload? Provider views from Malawi, South Africa, and Zambia
  B. Phiri *, A. Huber, V. Ntjikelane, T. Tchereni, J. Kaiser, P. Lumano Mulenga, M. M Mwenechanya, P. Haimbe, H. Shakwelele, R. Nyirenda, S. Ngoma, A. Gunde, B. Nichols, S. Rosen
• HIVST among children, adolescents, and pregnant and breastfeeding women: implementation results and enablers for scale-up
  C. Nwafor *, N. Otubu, A. Muhammad-Mujtaba, O. Adewole, M. Obioma, F. Lufadeju, J. Drakes, L. Simao, S. Dowling, K. Suggu, O. Wiwa
• Experiences and early lessons from adoption and introduction of the generic pediatric Dolutegravir 10mg dispersible, scored tablets (pDTG) in Malawi
  E. Longwe Matupa *, D. Telela, Y. Gumulira, C. Chimhundu, M. Maulidi, A. Gunda, R. Nyirenda
• The Uganda HIVDR Database: a data information exchange platform to improve HIV drug resistance (HIVDR) monitoring
  E. Twinomujuni *, A. Ayitewala, S.P. Muwanguzi, G. Kuboi, S.P. Atwiine, V. Nabitaka, P. Nambuya Mbabazi, C. Katureebe, M. Nakawuka, A. Ahimbisibwe, M.G. Alwano, Z. Guoqing, M. Steinau, E. Mary, E. Nazziwa, E. Namusoke Magongo
• Use of generic ritonavir-boosted darunavir and dolutegravir for second-line antiretroviral therapy is cost-effective in Zambia: a 10-year modeling analysis
  J. Campbell *, J. Estill, Z. Panos, J. Harwell, C. Chimhundu, H. Shakwelele, P. Haimbe, C. Amole, S. Sivile, L. Mulenga
• Expedited development and registration resulting in successful uptake of generic, pediatric dolutegravir products for low- and middle-income countries through an innovative public-private partnership
  M. Watkins, H. McDowell, L. Lewis, K. Hayward, M. Louey *, A. Djemai, S. Ghelani, K. Grainger, C. Amole
• Epidemiology of Human Papillomavirus genotypes and prevalence of cervical precancerous lesions among women living with HIV: results from a pilot cervical cancer screening program in Uganda
  M. Lubega *, C. Okiira, A. Nabaggala, C. Achola, Y. Kamuntu, A. Musoke, A. Abala, S. Ndidde
• Can an adolescent HIV psychosocial attrition risk assessment tool predict loss to follow-up? Preliminary findings from Uganda
  N. Medina-Jaudes *, D. Adoa, N. Aziz, K.J. Bosco, A. Carmone, S. Dowling, J. Joseph, E. Magongo Namusoke, K. Mary, M. Mbabazi, V. Nabitaka, B. Namayanja, K. Suggu, A. Williams, A. Musoke, T. Nabwire Chimulwa
• Comparison of Advanced HIV Disease identification using CD4 results from a semi-quantitative CD4 point of care test and CD4 flow cytometry in Nigeria
  N. Otubu *, O. Abudiore, M.-M. Akanmu, B. Levy-Braide, W. Eigege, O. Sowale, A. Inyang, D. Rathakrishnan, I. Amamilo, J. Conroy, F. Lufadeju, C. Amole, O. Wiwa, P. Nwaokenneya, C. Adesigbin, A. Ikpeazu, G. Olorunfemi, R. Oladele, O. Agbaji, S. Akanmu
• Perspective of healthcare workers in Nigeria on the introduction of new pediatric antiretroviral drugs: experiences, enablers, and barriers
  O. Sowale *, W. Eigege, O. Abudiore, B. Levy-Braide, N. Otubu, A. Inyang, J. Campbell, D. Rathakrishnan, I. Amamilo, F. Lufadeju, C. Amole, O. Wiwa, C. Adesigbin, E. Etiobhio, A. Ikpeazu, O. Agbaji, S. Akanmu, U. Lawal, S. Ochigbo, J. Conroy
• HIV prevention and treatment in the era of COVID-19 in South Africa
  P. Chituku *, V. Tshivase, Z. Kwinda, T. Chidarikire, Y. Pillay
• Implementation of the CD4 advanced disease rapid test: lessons learned from the pilot test in Uganda
  R. Kirungi *, V. Nabitaka, A. Nuwagira, A. Musoke, A. Omar, A. Moore, D. Rathakrishnan, J. Conroy, P.M. Namuwenge, W. Nyegenye, C. Okiira, V. Kasone, A. Carolyn J
• Improved tuberculosis case finding among patients with Advanced HIV Disease in Nigeria through the deployment of a point-of-care tuberculosis diagnostic test
  W. Eigege *, B. LevyBraide, N. Otubu, O. Abudiore, O. Sowale, A. Inyang, D. Rathakrishnan, J. Conroy, I. Amamilo, F. Lufadeju, C. Amole, O. Wiwa, C. Adesigbin, P. Nwaokenneya, A. Ikpeazu, R. Oladele, O. Agbaji, S. Akanmu
• Improved TB testing in Malawi following targeted supportive supervision for TB LAM uptake
  G. Saemisch, Y. Gumulira *, D. Telela, E. Matupa, B. Wilson, P. Nyasulu, R. Nyirenda, J. Mpunga